Business Wire

FLIR Provides Thermal Imaging for Next Generation DJI Zenmuse XT2 Dual-Sensor Commercial Drone Camera

Jaa

FLIR Systems, Inc. (NASDAQ: FLIR) today announced that DJI, the world’s leader in civilian drones and aerial imaging, will integrate a FLIR thermal imaging sensor technology into its new DJI Zenmuse XT2 drone camera. The DJI Zenmuse XT2, DJI’s first dual-sensor and its most advanced gimbal-stabilized camera for commercial drone applications, furthers the collaboration between FLIR® and DJI. The Zenmuse XT2 also joins the ‘Thermal by FLIR’ partner program, which FLIR created to fuel thermal innovation and allow partners to leverage the leadership, quality, and innovation that FLIR’s brand represents in the thermal imaging space.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180328006041/en/

Dual-sensor DJI Zenmuse XT2 with Thermal by FLIR (Photo: Business Wire)

Dual-sensor DJI Zenmuse XT2 with Thermal by FLIR (Photo: Business Wire)

Built with industrial and public safety applications in mind, the DJI Zenmuse XT2 expands upon the benefits in the first thermal-equipped camera jointly developed by FLIR and DJI, the DJI Zenmuse XT. The new drone camera includes both a high-definition 4K color video camera and a high-resolution radiometric thermal camera, allowing operators to switch between thermal and visible cameras in flight. The Zenmuse XT2 also uses FLIR’s patented MSX® technology, or multispectral dynamic imaging, that embosses high-fidelity, visible-light details onto the thermal imagery to enhance image quality and perspective.

The Zenmuse XT2 is compatible with the DJI Matrice 600 and Matrice 200 Series platforms and integrates with DJI’s data transmission technology for live video display. Full integration gives drone operators plug-and-play installation, real-time control, and recording during flight in thermal, visible, or thermal/visible picture-in-picture. This flexibility allows operators to acquire double the data in a single camera and stay focused on mission-critical tasks.

“The arrival of the DJI Zenmuse XT2 with a FLIR sensor signifies an important technological advancement for drone operators who need both a visible camera and the superpower benefits of thermal imaging in one product,” said James Cannon, President and CEO of FLIR. “Now drone operators can capture data without landing, an important advantage for search and rescues operations, monitor the health of mechanical and electrical equipment remotely, and identify potential problems in buildings. Our collaboration with DJI perfectly aligns with our mission to use our thermal technology to help save lives and livelihoods.”

“Since the introduction of our first FLIR camera in 2015 we have seen strong demand for thermal imaging-based products because they have helped transform DJI drones into essential and often lifesaving tools across a wide variety of industries,” said Roger Luo, President at DJI. “We are excited to introduce our next generation product together, the Zenmuse XT2, which is easier and more efficient to operate, and further demonstrates our commitment to innovation in the commercial drone industry.”

DJI is one of multiple partners involved with the new Thermal by FLIR program, created to support original equipment manufacturers (OEMs) and product innovators interested in using the FLIR thermal imaging sensors to deliver the benefits of the World’s Sixth Sense. The program ensures that original equipment manufacturers and entrepreneurs can carry the Thermal by FLIR brand and receive additional product development and marketing support from FLIR to build and market their respective products. Additional Thermal by FLIR partners include Cat Phones, Casio, Panasonic, ARSENZ, and TinkerForge.

To learn more about the Zenmuse XT2, visit www.flir.com/xt2. For device manufacturers interested in learning more about integrating FLIR sensors, please visit http://www.flir.com/thermalbyflir/.

About FLIR Systems

Founded in 1978 and headquartered in Wilsonville, Oregon, FLIR Systems is a world-leading maker of sensor systems that enhance perception and heighten awareness, helping to save lives, improve productivity, and protect the environment. Through its nearly 3,500 employees, FLIR's vision is to be "The World's Sixth Sense" by leveraging thermal imaging and adjacent technologies to provide innovative, intelligent solutions for security and surveillance, environmental and condition monitoring, outdoor recreation, machine vision, navigation, and advanced threat detection. For more information, please visit  www.flir.com  and follow  @flir .

Forward-Looking Statements

The statements of opinion in this release that are not historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are based on current expectations, estimates, and projections about FLIR's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks and uncertainties that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including risks and uncertainties discussed from time to time in FLIR's Securities and Exchange Commission filings and reports. Such forward-looking statements speak only as of the date on which they are made and FLIR does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this release, or for changes made to this document by wire services or Internet service providers.

The company names, logos, brands, and other trademarks featured or referred to herein are the property of their respective trademark holders. These trademark holders are not affiliated with FLIR Systems, its affiliates or its products.

Contact information

FLIR Systems, Inc.
Media:
Tim McDowd, 503-498-3146
tim.mcdowd@flir.com
or
Investor Relations:
Shane Harrison, 503-498-3547
shane.harrison@flir.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

BioNTech Signs Collaboration Agreement with Pfizer to Develop mRNA-based Vaccines for Prevention of Influenza16.8.2018 08:00Tiedote

BioNTech AG, a rapidly growing biotechnology company focused on precise immunotherapies for the treatment of cancer and infectious disease, today announced that it has entered into a multi-year research and development (R&D) collaboration with Pfizer Inc. (NYSE: PFE) to develop mRNA-based vaccines for prevention of influenza (flu). Under the terms of the agreement, BioNTech and Pfizer will jointly conduct research and development activities to help advance mRNA-based flu vaccines. Pfizer will assume sole responsibility for further clinical development and commercialization of mRNA-based flu vaccines, following BioNTech’s completion of a first in human clinical study. BioNTech will receive $120 million in upfront, equity and near-term research payments and up to an additional $305 million in potential development, regulatory and commercial milestone payments. In addition, BioNTech will receive up to double-digit tiered royalty payments associated with worldwide sales if the program reac

Maxion Wheels to Showcase Market-Leading Light Weight Commercial Vehicle Wheels at REIFEN 201816.8.2018 07:05Tiedote

Maxion Wheels, the world’s largest producer of wheels, announced today its participation in REIFEN, the leading tire and wheel industry event in Europe, from Sept. 11 – 15, 2018 in Hall 12.1 / Stand D24. For the first time, REIFEN will be co-located with Automechanika Frankfurt at the Messe Frankfurt. “REIFEN is the premier event for European tire and wheel manufacturers and resellers, bringing us together to meet and collaborate on the important aftermarket themes of innovation, service and delivery,” stated Mark Gerardts, Vice President of Global Sales and Marketing, Maxion Wheels. “After a highly popular launch to truck and trailer OEMs in 2017, we’re excited to have the industry’s lightest mass production steel wheel now available to our aftermarket distributors. This wheel, along with several others, including our new 10.00W-20 wide base tubetype and tubeless heavy duty armored vehicles wheel are great examples of our continued efforts to bring our OE multi-application innovations

Lenovo Accelerates Turnaround with Back-to-Back, Double-Digit Quarterly Revenue Growth16.8.2018 02:40Tiedote

Lenovo Group (HKSE: 0992) (PINK SHEETS: LNVGY) today announced results for its first fiscal quarter ended June 30, 2018. For the second straight quarter, Lenovo achieved strong double-digit growth in revenue year-on-year. Group revenue reached US$11.91 billion, up 19% year-on-year. The company also reported strong pre-tax income during the quarter of US$113 million, an improvement of US$182 million year-on-year, as profitability improved across all businesses. In the first fiscal quarter, Lenovo’s profit attributable to equity holders grew to US$77 million, up US$149 million year-over-year. Basic earnings per share in the first fiscal quarter was 0.65 US cents or 5.10 HK cents. “As we persistently execute our 3-wave strategy, all our businesses made solid improvements in both revenue and profitability. Lenovo has passed the turning point and entered a phase of ‘acceleration’ - accelerating the execution of our transformation strategy and accelerating the rising momentum in business per

CORRECTING and REPLACING Ebola Successfully Neutralized by Latest Generation Polyclonal Immunotherapy16.8.2018 01:37Tiedote

Please replace the release with the following corrected version due to multiple revisions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180815005602/en/ New Ebola immunotherapy developed by SAB Biotherapeutics uses natural human polyclonal antibodies to combat disease. (Photo: SAB Biotherapeutics) The corrected release reads: EBOLA SUCCESSFULLY NEUTRALIZED BY LATEST GENERATION POLYCLONAL IMMUNOTHERAPY Promising new platform can rapidly respond to emerging infectious diseases Sioux Falls, SD, August 15, 2018 – SAB Biotherapeutics, Inc. (SAB), a clinical-stage biopharmaceutical company, today announced that its anti-Ebola immunotherapy (SAB-139) provided “100% protection against a lethal dose of the Ebola virus” in a recent animal study published in The Journal of Infectious Diseases . The study was conducted at the Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of He

QConnect – Markkinoiden älykkäin, erittäin kompakti ja lujatekoinen viestintälaite15.8.2018 23:23Tiedote

Quake Global, Inc. (QUAKE), yksi maailman johtavista IoT-markkinoiden toimittajista, julkaisi QConnect™, uuden sukupolven kehittyneen telematiikkalaitteen. Äärimmäisen kompakti QConnect integroituu kiinteisiin ja liikkuviin omaisuuksiin niiden seuraamiseksi, valvomiseksi ja hallitsemiseksi reaaliajassa mistä ja milloin tahansa. Laite tarjoaa useita pitkälle kehitettyjä langattomia kommunikaatiovaihtoehtoja, mukaan lukien LTE/2G/3G, kaksitaajuus-Wi-Fi, Bluetooth/BLE, V2X ja satelliitti. Laite on suunniteltu vastaamaan moniin eri vaatimuksiin yksinkertaisista ja edullisista seurantasovelluksista aina korkean suorituskyvyn monikanavaisiin videon suoratoistosovelluksiin. Tämä lehdistötiedote sisältää multimediaa. Katso koko julkaisu täällä: https://www.businesswire.com/news/home/20180815005706/fi/ Quake Global’s new QConnect, the most intelligent, global, ultra-compact and rugged communication device available (Photo: Business Wire) QConnect tarjoaa joustavuutta sen ainutlaatuisilla sovell

Ebola Successfully Neutralized by Latest Generation Polyclonal Immunotherapy15.8.2018 20:43Tiedote

SAB Biotherapeutics, Inc. (SAB), a clinical-stage biopharmaceutical company, today announced that its anti-Ebola immunotherapy (SAB-139) provided “100% protection against a lethal dose of the Ebola virus” in a recent animal study published in The Journal of Infectious Diseases . The study was conducted by the National Interagency Confederation for Biological Research and other collaborators including United States Army Medical Research Institute of Infectious Diseases (USAMRIID) and the Naval Medical Research Center (NMRC). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180815005602/en/ New Ebola immunotherapy developed by SAB Biotherapeutics uses natural human polyclonal antibodies to combat disease. (Photo: SAB Biotherapeutics) According to the World Health Organization, Ebola virus disease (EVD), formerly known as Ebola hemorrhagic fever, is a severe, often fatal illness in humans with an average fatality rate around 50%.

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme